Health Canada grants Cultivation, Processing & Medical Sales Licences to GTEC Subsidiary Tumbleweed Farms
20 August 2019 - 12:34AM
- Tumbleweed Receives Cultivation, Processing and Medical Sales
Licences
- GTEC now owns three licensed cultivation facilities, including
two facilities licensed for both medical sales and Provincial
adult-use sales
- Estimated Annual production of 4,000 kg of indoor flower
- Executed all three Health Canada licensing milestones for
2019
- Cultivation has immediately commenced at Tumbleweed
GTEC Holdings Ltd. (TSX-V:GTEC) (OTCQB:GGTTF) (FRA:1BUP)
(“GTEC” or the “Company”), a vertically integrated
premium cannabis producer, is pleased to announce that its
wholly-owned subsidiary, Tumbleweed Farms Inc.
(“Tumbleweed”), was granted Standard Cultivation, Standard
Processing and Medical Sales Licences, pursuant to the Cannabis Act
and Regulations by Health Canada on August 16, 2019.With the
licensing of Tumbleweed, management expects the following forecasts
across the organization's three operational cultivation
facilities:
- Estimated Annual production of 4,000 kg of flower and 1,000 kg
trim
- GTEC to achieve positive cash flow in the near future, upon
Tumbleweed and Grey Bruce entering into full production and
sales
GTEC is currently implementing its new cultivars into Alberta
Craft Cannabis (“ACC”) and will transition its sales efforts
from B2B wholesale, to Provincial & Territorial adult-use
supply chains and direct to medical patients, with the expectation
that its average selling price will increase. The Company
anticipates the completion of two more facilities (GreenTec
Bio-Pharma and 3PL) in the near future, which is expected to
increase the organization’s production output in 2020.Within the
most recent six weeks, the Company has successfully executed on
accomplishing all three of its cannabis licensing objectives for
2019, which include the following:
- Standard Cultivation Licence at Grey Bruce Farms - July 5,
2019
- Standard Processing and Medical Sales Licence at Alberta Craft
Cannabis - July 26, 2019
- Standard Cultivation, Processing and Medical Sales Licence at
Tumbleweed Farms - August 16, 2019
“We are incredibly proud of the dedication and commitment of our
subsidiaries in accomplishing the most recently issued licences,”
said Norton Singhavon, GTEC Founder Chairman and CEO. “As the
organization progresses in the direction of profitability, we will
persevere to ensure that Tumbleweed and Grey Bruce become cash flow
positive in the near future, while striving to complete the
build-outs of GreenTec Bio-Pharma and 3PL.”In accordance with the
Cannabis Act and Regulations, Tumbleweed has immediately commenced
cultivation of cannabis plants from a portfolio of high-end
cultivars (more commonly known as genetics). Management believes
that its combination of unique genetics and experienced cultivation
techniques will create a long-term sustainable competitive
advantage for the Company and provide resistance to overall price
compression.Tumbleweed is a purpose-built cultivation facility
located in Chase, British Columbia. This facility was designed,
constructed and equipped in a manner intended to optimize its
ability to produce the highest quality cannabis flower. The initial
phase of the facility is 10,000 sq. ft. and is projected to produce
1,000 kg of cannabis flower annually, with significant expansion
capabilities.About GTECGTEC Holdings is a specialized
cannabis company dedicated to cultivating ultra-premium quality
cannabis in purpose-built indoor facilities. The company is
vertically integrated across all major sectors of the Canadian
cannabis industry and currently holds the following licences issued
by Health Canada pursuant to the Cannabis Act and Regulations;
three Standard Cultivation licences estimated to produce 4,000 kg
of indoor flower annually, two Standard Processing licences (for
adult-use sales into the Provincial supply chains), two Medical
Sales licences (for direct to medical patients), Standard
Processing (for extraction), and Analytical Testing.The management
team is comprised of a diverse skill set sourced from leading
global food & beverage, CPG and premium alcohol companies. GTEC
has completed three cultivation facilities and is currently
cultivating and selling cannabis. GTEC’s retail division is
pursuing licensing for recreational cannabis stores across Western
Canada.GTEC’s genetic portfolio is comprised of over 30 unique
cultivars that have been developed through a comprehensive
phenotyping process, which is expected to deliver a sustainable
competitive advantage and provide favourable gross margins. GTEC’s
ultra-premium indoor flower will be marketed and sold under its
flagship trademarked brands; BLK MKT™, Tenzo™, GreenTec™,
Cognōscente™ and Treehugger™.GTEC is actively pursuing sales and
distribution opportunities across all major business channels:
medical, recreational, B2B and export. GTEC is a publicly traded
corporation, listed on the TSX Venture Exchange, OTCQB Venture
Market and Frankfurt Stock Exchange. The Company is headquartered
in Kelowna, British Columbia.To view more about the company or to
download our most recent corporate presentation, please visit our
website at www.gtec.coOn behalf of the board,Norton
SinghavonFounder, Chairman & CEOMichael BladyCo-Founder &
Vice PresidentNeither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.CAUTIONARY STATEMENT REGARDING
FORWARD-LOOKING INFORMATION:This news release includes certain
“forward-looking statements” under applicable Canadian securities
legislation. Forward-looking statements are necessarily based upon
a number of estimates and assumptions that, while considered
reasonable, are subject to known and unknown risks, uncertainties,
and other factors which may cause the actual results and future
events to differ materially from those expressed or implied by such
forward-looking statements. Such factors include, but are not
limited to: general business, economic, competitive, political and
social uncertainties; delay or failure to receive board,
shareholder or regulatory approvals, where applicable; and the
state of the capital markets. There can be no assurance that such
statements will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
statements. For instance, there can be no assurance that the
Company’s overall annual production will increase to 4,000 kg of
flower and 1,000 kg of trim; that GTEC will achieve positive
cashflow; that the Company’s facilities will enter into full
production, output and sales; that GTEC will achieve a weighted
average selling price of $5 per gram between both flower and trim;
that ACC will successfully transition its sales efforts from B2B to
wholesale; that ACC’s average selling price of flower and trim will
increase; that GreenTec Bio-Pharma and 3PL facilities (the
“Facilities”) will be completed; that upon completion of the
Facilities, the Company’s annual production output of flower and
trim will increase; that Tumbleweed will be revenue
generating; that Tumbleweed will be able to produce the highest
quality cannabis flower; that the Company’s genetics and
cultivation techniques will create a sustainable competitive
advantage for the Company; that Tumbleweed will be able to produce
1,000 kg of cannabis flower annually. Accordingly, readers should
not place undue reliance on forward-looking statements. The Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.
For additional information, please contact:
GTEC Holdings Ltd.
1-800-351-6358
contact@gtec.co
GTEC (TSXV:GTEC)
Historical Stock Chart
From Dec 2024 to Jan 2025
GTEC (TSXV:GTEC)
Historical Stock Chart
From Jan 2024 to Jan 2025